Primo Medical Group announced that it completed the $100 million sale of spin-off company Arthrosurface to Anika Therapeutics (NSDQ:ANIK). Under the agreement, Anika is set to acquire all outstanding shares of Arthrosurface in exchange for $100 million in total, starting with an upfront payment of approximately $60 million in cash from Anika’s existing balance sheet. The […]
Primo Medical Group
Versago raises $1.7m for ‘reverse needle’ access port
Versago Vascular Access said today it received $1.7 million in seed funding from Primo Medical Group’s network of investors to support its “reverse needle” subcutaneous access port. West Bridgewater, Mass.-based Versago, a spinoff of Primo Medical Group, has designed and developed a subcutaneous port to access the body’s bloodstream and anatomical cavities that collect serous […]